Literature DB >> 26965517

Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease.

Hironobu Fujii1, Shinichiro Shinzaki2, Hideki Iijima2, Kana Wakamatsu1, Chizuru Iwamoto1, Tomoaki Sobajima1, Ryusuke Kuwahara3, Satoshi Hiyama2, Yoshito Hayashi2, Shinji Takamatsu1, Naofumi Uozumi1, Yoshihiro Kamada4, Masahiko Tsujii2, Naoyuki Taniguchi5, Tetsuo Takehara2, Eiji Miyoshi6.   

Abstract

BACKGROUND & AIMS: Attachment of a fucose molecule to the innermost N-glycan in a glycoprotein (core fucosylation) regulates the activity of many growth factor receptors and adhesion molecules. The process is catalyzed by α1-6 fucosyltransferase (FUT8) and required for immune regulation, but it is not clear whether this process is dysregulated during disease pathogenesis. We investigated whether core fucosylation regulates T-cell activation and induction of colitis in mice, and is altered in patients with inflammatory bowel disease (IBD).
METHODS: Biopsy samples were collected from inflamed and noninflamed regions of intestine from patients (8 with Crohn's disease, 4 with ulcerative colitis, and 4 without IBD [controls]) at Osaka University Hospital. Colitis was induced in FUT8-deficient (Fut8(-/-)) mice and Fut8(+/+) littermates by administration of trinitrobenzene sulfonic acid. Intestinal tissues were collected and analyzed histologically. Immune cells were collected and analyzed by lectin flow cytometry, immunofluorescence, and reverse-transcription polymerase chain reaction, as well as for production of cytokines and levels of T-cell receptor (TCR) in lipid raft fractions. T-cell function was analyzed by intraperitoneal injection of CD4(+)CD62L(+) naïve T cells into RAG2-deficient mice.
RESULTS: Levels of core fucosylation were increased on T cells from mice with colitis, compared with mice without colitis, as well as on inflamed mucosa from patients with IBD, compared with their noninflamed tissues or tissues from control patients. Fut8(-/-) mice developed less-severe colitis than Fut8(+/+) mice, and T cells from Fut8(-/-) mice produced lower levels of T-helper 1 and 2 cytokines. Adoptive transfer of Fut8(-/-) T cells to RAG2-deficient mice reduced the severity of colitis. Compared with CD4(+) T cells from Fut8(+/+) mice, those from Fut8(-/-) mice expressed similar levels of TCR and CD28, but these proteins did not contain core fucosylation. TCR complexes formed on CD4(+) T cells from Fut8(-/-) mice did not signal properly after activation and were not transported to lipid rafts.
CONCLUSIONS: Core fucosylation of the TCR is required for T-cell signaling and production of inflammatory cytokines and induction of colitis in mice. Levels of TCR core fucosylation are increased on T cells from intestinal tissues of patients with IBD; this process might be blocked as a therapeutic strategy.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation; Glycosylation; Oligosaccharide; T-Cell Signaling

Mesh:

Substances:

Year:  2016        PMID: 26965517     DOI: 10.1053/j.gastro.2016.03.002

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation.

Authors:  Seita Tomida; Misaki Takata; Tetsuya Hirata; Masamichi Nagae; Miyako Nakano; Yasuhiko Kizuka
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation.

Authors:  Bobby G Ng; Gege Xu; Nandini Chandy; Joan Steyermark; Deepali N Shinde; Kelly Radtke; Kimiyo Raymond; Carlito B Lebrilla; Ali AlAsmari; Sharon F Suchy; Zöe Powis; Eissa Ali Faqeih; Susan A Berry; David F Kronn; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

Review 3.  Emerging role of protein modification in inflammatory bowel disease.

Authors:  Gaoying Wang; Jintao Yuan; Ji Luo; Dickson Kofi Wiredu Ocansey; Xu Zhang; Hui Qian; Wenrong Xu; Fei Mao
Journal:  J Zhejiang Univ Sci B       Date:  2022-03-15       Impact factor: 3.066

4.  Glycosylation in Autoimmune Diseases.

Authors:  Marta Ząbczyńska; Paweł Link-Lenczowski; Ewa Pocheć
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  N-Glycosylation.

Authors:  Tetsuya Hirata; Yasuhiko Kizuka
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

6.  Characterizing human α-1,6-fucosyltransferase (FUT8) substrate specificity and structural similarities with related fucosyltransferases.

Authors:  Bhargavi M Boruah; Renuka Kadirvelraj; Lin Liu; Annapoorani Ramiah; Chao Li; Guanghui Zong; Gerlof P Bosman; Jeong-Yeh Yang; Lai-Xi Wang; Geert-Jan Boons; Zachary A Wood; Kelley W Moremen
Journal:  J Biol Chem       Date:  2020-10-01       Impact factor: 5.157

7.  Structural basis of substrate recognition and catalysis by fucosyltransferase 8.

Authors:  Michael A Järvå; Marija Dramicanin; James P Lingford; Runyu Mao; Alan John; Kate E Jarman; Rhys Grinter; Ethan D Goddard-Borger
Journal:  J Biol Chem       Date:  2020-03-27       Impact factor: 5.157

Review 8.  Antibody glycosylation in autoimmune diseases.

Authors:  Xing Zhou; Francesca Motta; Carlo Selmi; William M Ridgway; M Eric Gershwin; Weici Zhang
Journal:  Autoimmun Rev       Date:  2021-03-14       Impact factor: 9.754

9.  Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning.

Authors:  Won Ho Yang; Julia S Westman; Douglas M Heithoff; Markus Sperandio; Jin Won Cho; Michael J Mahan; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

10.  Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT.

Authors:  Li Jia; Jun Li; Pengfei Li; Didi Liu; Jing Li; Jiechen Shen; Bojing Zhu; Chen Ma; Ting Zhao; Rongxia Lan; Liuyi Dang; Wang Li; Shisheng Sun
Journal:  Theranostics       Date:  2021-05-08       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.